Survival Benefit of Primary Tumor Treatment in Uveal Melanoma: A Re-Analysis of the Collaborative Ocular Melanoma Study (COMS) and Natural History Study (NHS) Cohorts
In this re-evaluation, patients who declined treatment for medium-sized choroidal melanomas had significantly worse survival, suggesting a potential survival benefit of primary tumor treatment.
Authors
- Gustav Stålhammar (ORCID: https://orcid.org/0000-0001-9401-8911)
- Hans Witzenhausen
Institutions
- Karolinska Institutet (SE)
- S:t Eriks Ögonsjukhus (SE)
Publication Details
- Journal
- Cancers
- Published
- 2024-11-15
- DOI
- https://doi.org/10.3390/cancers16223839
- Citations
- 3
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.62
Funders
- Cancerfonden
- Svenska Läkaresällskapet